Insmed Announces Strategic Financings Totaling $775 Million
https://investor.insmed.com/2022-10-19-Insmed-Announces-Strategic-Financings-Totaling-775-Million
WEBOct 19, 2022 · BRIDGEWATER, N.J., Oct. 19, 2022 / PRNewswire / -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced three strategic financings resulting in aggregate gross proceeds of $775 million.
DA: 95 PA: 12 MOZ Rank: 91 Up or Down: Up